Economic evaluation of drug-eluting stents in Japan

Keio Journal of Medicine

Volumn 55, Issue 1, 2006, Pages 15-22

  Ikeda, Shunya ^a   Kobayashi, Mia ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Medical cost; Restenosis; Sirolimus eluting stent

Indexed keywords

RAPAMYCIN;

ARTICLE; CONTROLLED STUDY; COST CONTROL; DRUG ELUTING STENT; ECONOMIC EVALUATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; JAPAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; REVASCULARIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; HEALTH CARE COSTS; HUMANS; METALS; SIROLIMUS; STENTS;

EID: 33646585182     PISSN: 00229717     EISSN: 00229717     Source Type: Journal    
DOI: 10.2302/kjm.55.15     Document Type: Article

References (24)

1. Kozuma K: Drug eluting stent. Coronary Intervention 2002; 1 (1): 58-62
2. Lemos PA, Serruys PW, Sousa JE: Drug-eluting stents: cost versus clinical benefit. Circulation 2003; 107: 3003-3007
3. Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF, Kozuma K, Van Langenhove G, Sousa AG, Falotico R, et al: Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104: 2007-2011
4. Sousa JE, Costa MA, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS, Feres F, Mattos LA, Falotico R, Jaeger J, et al: Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003; 107: 381-383
5. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, et al: RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions: A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780
6. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, et al: SIRIUS Investigators: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323
7. Gunn J, Morton AC, Wales C, Newman CM, Crossman DC, Cumberland DC: Drug eluting stents: maximising benefit and minimising cost. Heart 2003; 89: 127-131
8. Cohen DJ, Bakhai A, Shi C, Githiora L, Lavelle T, Berezin RH, Leon MB, Moses JW, Carrozza JP Jr, Zidar JP, et al: SIRIUS Investigators: Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation 2004; 110: 508-514
9. Taylor RS, Hutton J, Culyer AJ: Developing the revised NICE appraisal technical guidance to manufacturers and sponsors: opportunity or threat? Pharmacoeconomics 2002; 20: 1031-1038
10. Ikeda S, Bosch J, Banz K, Schneller P: Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan. J Invasive Cardiol 2000; 12: 194-199
11. Holmes DR Jr, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, Brown C, Fischell T, Wong SC, Midei M, et al: Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004; 109: 634-640
12. Noda T, Fujiwara H: PTCA and CABG in Japan from the economic viewpoint. Jpn Circ J 2000; 64 (Suppl 1): 54
13. Shihara M, Tsutsui H, Tsuchihashi M, Shigematsu H, Yamamoto S, Koike G, Kono S, Takeshita A; Japanese Coronary Intervention Study (JCIS) Group: Coronary revascularization in Japan. Part 3: percutaneous coronary intervention during 1997. Circ J 2002; 66: 10-19
14. Shigematsu H, Tsutsui H, Shihara M, Tsuchihashi M, Koike G, Yamamoto S, Kono S, Takeshita A; Japanese Coronary Intervention Study (JCIS) Group: Coronary revascularization in Japan. Part 4: coronary artery bypass surgery during 1997. Circ J 2002; 66: 20-29
15. Okawa I: Minimally invasive surgery and health economics. In: Kyo S, ed
16. Tsuda Y, Takemura T, Shimamura Y, Iwasa S: Economic evaluation of off-pump coronary artery bypass grafting; compared to conventional coronary artery bypass grafting. Kyobu Geka 2003; 56: 718-721
17. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds, Cost-Effectiveness in Health and Medicine, 1st edition, New York, Oxford University Press, 1996
18. National Institute for Clinical Excellence, Guide to the Methods of Technology Appraisal, April 2004, London, National Institute for Clinical Excellence, 2004. Available from: http://www.nice.org.uk/pdf/TAP_Methods.pdf
19. O'Neill WW, Leon MB: Drug-eluting stents: costs versus clinical benefit. Circulation 2003; 107: 3008-3011
20. Kong DF, Eisenstein EL, Sketch MH Jr, Zidar JP, Ryan TJ, Harrington RA, Newman MF, Smith PK, Mark DB, Califf RM: Economic impact of drug-eluting stents on hospital systems: a disease-state model. Am Heart J 2004; 147: 449-456
21. Kereiakes DJ: Hippocrates revisited: the evidence for drug-eluting stents. Circulation 2003; 107: 3012-3014
22. Williams DO, Holubkov R, Yeh W, Bourassa MG, Al-Bassam M, Block PC, Coady P, Cohen H, Cowley M, Dorros G, et al: Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation 2000; 102: 2945-2951
23. Kiemeneij F, Serruys PW, Macaya C, Rutsch W, Heyndrickx G, Albertsson P, Fajadet J, Legrand V, Materne P, Belardi J, et al: Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. J Am Coll Cardiol 2001; 37: 1598-1603
24. Donohoe D: Physician letter on SATs in Association with the CYPHER Coronary Stent [dated 2003 July 7; cited 2004 September 25]. Available from: http://www.cordis.com/active/crdus/en_US/html/cordis/downloads/Letter.pdf